Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Compliance with antihypertensive therapy: raising the bar of expectations.

Rudd P.

Am J Manag Care. 1998 Jul;4(7):957-66. Review.

2.

Hypertension and current issues in compliance and patient outcomes.

Zyczynski TM, Coyne KS.

Curr Hypertens Rep. 2000 Dec;2(6):510-4. Review.

PMID:
11062595
3.

Methods to improve medication adherence in patients with hypertension: current status and future directions.

Krousel-Wood M, Hyre A, Muntner P, Morisky D.

Curr Opin Cardiol. 2005 Jul;20(4):296-300. Review.

PMID:
15956826
4.
5.

What factors contribute to the inadequate control of elevated blood pressure?

Elliott WJ.

J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):20-6. Review.

6.

The economic impact of hypertension.

Elliott WJ.

J Clin Hypertens (Greenwich). 2003 May-Jun;5(3 Suppl 2):3-13. Review.

7.

Issues in blood pressure control and the potential role of single-pill combination therapies.

Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM.

Int J Clin Pract. 2009 May;63(5):790-8. doi: 10.1111/j.1742-1241.2009.01999.x. Epub 2009 Feb 11. Review.

PMID:
19220523
8.

Clinicians and patients with hypertension: unsettled issues about compliance.

Rudd P.

Am Heart J. 1995 Sep;130(3 Pt 1):572-9. Review.

PMID:
7661077
9.

Managing the patient with hard-to-control hypertension.

Oparil S, Calhoun DA.

Am Fam Physician. 1998 Mar 1;57(5):1007-14, 1019-20. Review.

10.

Existing treatment strategies: does noncompliance make a difference?

Caro JJ, Speckman JL.

J Hypertens Suppl. 1998 Sep;16(7):S31-4. Review.

PMID:
9855029
11.

Reducing costs and improving compliance.

Neal WW.

Am J Cardiol. 1989 Jan 17;63(4):17B-20B. Review.

PMID:
2643288
12.

Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.

Krousel-Wood M, Thomas S, Muntner P, Morisky D.

Curr Opin Cardiol. 2004 Jul;19(4):357-62. Review.

PMID:
15218396
13.

Improving compliance with antihypertensive therapy.

Moore MA.

Am Fam Physician. 1988 Jan;37(1):142-8. Review.

PMID:
3276096
14.

Compliance and the benefit/risk relationship of antihypertensive treatment.

Hasford J.

J Cardiovasc Pharmacol. 1992;20 Suppl 6:S30-4. Review.

PMID:
1283186
15.

Pharmacoeconomic burden of undertreating hypertension.

Degli Esposti L, Valpiani G.

Pharmacoeconomics. 2004;22(14):907-28. Review.

PMID:
15362928
16.

Taking antihypertensive medication--controlling or co-operating with patients?

Kjellgren KI, Ahlner J, Säljö R.

Int J Cardiol. 1995 Jan 6;47(3):257-68. Review.

PMID:
7721502
17.

Angiotensin receptor blockers: impact on costs of care.

[No authors listed]

Am J Manag Care. 2005 Nov;11(13 Suppl):S400-3. Review.

18.

Overcoming barriers to effective blood pressure control in patients with hypertension.

Düsing R.

Curr Med Res Opin. 2006 Aug;22(8):1545-53. Review.

PMID:
16870079
19.

Cost-effectiveness of hypertension treatment.

Ménard J.

Clin Exp Hypertens. 1996 Apr-May;18(3-4):399-413. Review.

PMID:
8743030
20.

Hypertension can be treated effectively without increasing the cost of care.

Moser M.

J Hum Hypertens. 1996 Feb;10 Suppl 2:533-8. Review.

PMID:
8868042

Supplemental Content

Support Center